GRAGNANI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.458
EU - Europa 2.199
AS - Asia 398
SA - Sud America 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.450
PL - Polonia 983
IE - Irlanda 356
SE - Svezia 288
IT - Italia 269
HK - Hong Kong 161
CN - Cina 130
DE - Germania 83
FI - Finlandia 74
UA - Ucraina 42
GB - Regno Unito 40
VN - Vietnam 39
TR - Turchia 30
JO - Giordania 25
ES - Italia 16
BE - Belgio 14
RU - Federazione Russa 12
CA - Canada 8
CH - Svizzera 7
FR - Francia 7
NL - Olanda 6
IN - India 5
BR - Brasile 4
KR - Corea 3
SG - Singapore 3
JP - Giappone 2
AT - Austria 1
AU - Australia 1
BF - Burkina Faso 1
EG - Egitto 1
EU - Europa 1
MD - Moldavia 1
Totale 6.063
Salva come PNG Salva come JPEG
Città #
Warsaw 980
Fairfield 545
Dublin 356
Ashburn 305
Chandler 287
Woodbridge 264
Seattle 229
Cambridge 226
Wilmington 216
Houston 196
Ann Arbor 146
Altamura 105
Beijing 99
Lawrence 94
Princeton 93
Hong Kong 88
Florence 76
Jacksonville 71
Buffalo 65
Bremen 51
Boston 50
Boardman 49
Medford 49
San Diego 33
Dong Ket 32
Falls Church 31
Izmir 28
New York 26
Norwalk 18
Shanghai 18
Brussels 14
Washington 14
Andover 11
Barcelona 9
Moscow 9
Bern 7
Hillsboro 7
Rome 7
Salerno 7
Nanjing 6
Old Bridge 6
Phoenix 6
Aachen 5
Auburn Hills 5
London 5
Toronto 5
Avigliano 4
Madrid 4
Cagliari 3
Caserta 3
Castelfiorentino 3
Ferriere 3
Helsinki 3
Pistoia 3
Pune 3
Redmond 3
Redwood City 3
Singapore 3
Ankara 2
Bastia umbra 2
Fuzhou 2
Kofu 2
Laurel 2
Meppel 2
Montréal 2
Naaldwijk 2
Osimo 2
Prato 2
Radomsko 2
Santo André 2
Tappahannock 2
Viterbo 2
Amsterdam 1
Atlanta 1
Bergamo 1
Bologna 1
Brisbane 1
Brooklyn 1
Catanzaro 1
Cervia 1
Chisinau 1
Chiswick 1
Civitanova Marche 1
Dearborn 1
Düsseldorf 1
El Ejido 1
Falkenstein 1
Frankfurt Am Main 1
Gdansk 1
Grevenbroich 1
Groningen 1
Guangzhou 1
Hanoi 1
Hefei 1
Hounslow 1
Incisa 1
Islington 1
Jiaxing 1
Kilburn 1
Kunming 1
Totale 5.043
Salva come PNG Salva come JPEG
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 219
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 214
HCV and lymphoproliferation 199
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. 194
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection. 189
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 155
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 125
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 121
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 121
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment 120
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy 119
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review 117
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 116
A serum metabolomic analysis of HCV-infected patients successfully treated with IFN-free DAA regimens 116
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 111
Host genetic determinants in HCV-related mixed cryoglobulinemia 108
MicroRNA expression in hepatitis C virus-related malignancies: A brief review 107
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 106
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement 106
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 104
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 94
Host genetic determinants in HCV-related mixed cryoglobulinemia 94
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 92
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 89
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 86
Longitudinal evaluation of liver stiffness and outcomes in patients with chronic hepatitis C before and after short- and long-term IFN-free antiviral treatment 84
HCV-related rheumatic manifestations and therapeutic strategies 81
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 80
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 79
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 79
Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame? 72
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. 72
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 71
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 70
Host genetic determinants in HCV-related mixed cryoglobulinemia 68
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 65
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 65
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 65
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 64
The Hepatitis C Virus Infection as a Systemic Disease 63
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 62
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection. 60
Crioglobulinemia e linfoma in corso di infezione da HCV 60
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 59
Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis. 57
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response. 55
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label cohort study. 55
HERG K+ channels activation during beta(1) integrin-mediated adhesion to fibronectin induces an up-regulation of alpha(v)beta(3) integrin in the preosteoclastic leukemia cell line FLG 29.1. 53
Extrahepatic manifestations of chronic hepatitis C virus infection. 53
Hepatitis C virus infection, malignancy and liver transplantation 50
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 49
HCV infection and carotid atherosclerosis: evidence in favour of a local viral action inside the plaque 48
Comportamento dell'infezione da HCV in pazienti trapiantati per HCC complicante una cirrosi HCV-correlata 48
null 48
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis 46
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 44
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 44
Hepatitis C virus lymphotrophism: lesson from a decade of studies 43
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders 43
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 41
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE 41
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 40
HCV AND lymphoma: Genetic and epigenetic factors 40
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 38
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 37
HCV-related lymphatic and hepatic malignancies are associated with different microRNA expression patterns in PBMCs 37
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 37
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 37
Hepatitis C-associated B-cell non-Hodgkin lymphomas: The emerging role of miRNA-26 36
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 33
Effects of depletion of B cell by anti-CD20 monoclonal antibody in HCV+ mixed cryoglobulinemia (MC) and liver cirrhosis 33
The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis 33
Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life 33
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 32
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 32
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 31
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 30
IL28B POLYMORPHISM AS PREDICTOR OF RESPONSE TO ANTI-HCV THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME 29
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 28
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 26
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 25
Il riarrangiamento del bcl-2: un nuovo evento oncogenetico nei linfomi malt di soggetti HCV infetti 21
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort 20
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 16
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 15
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 14
Totale 6.112
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019498 0 0 0 0 0 0 0 0 0 102 219 177
2019/20201.320 103 93 33 101 141 147 135 158 143 135 117 14
2020/2021963 88 60 42 152 49 86 49 78 88 163 51 57
2021/2022634 10 49 30 31 40 42 16 43 30 31 96 216
2022/20231.550 140 257 91 119 118 293 211 78 170 8 40 25
2023/2024489 20 74 96 25 28 105 8 107 11 15 0 0
Totale 6.112